Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 2/2014

01.03.2014 | Review

Cognitive dysfunction and depression in Fabry disease: a systematic review

verfasst von: Fay E. Bolsover, Elaine Murphy, Lisa Cipolotti, David J. Werring, Robin H. Lachmann

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Fabry disease, an X-linked lysosomal storage disorder, leads to multi-organ dysfunction, including cerebrovascular disease and psychological disorders. However, the prevalence and pattern of associated cognitive dysfunction is not well understood.

Objectives

To investigate whether there is reliable evidence for neuropsychological impairment in patients with Fabry disease and which cognitive domains are affected. To estimate the prevalence of and factors associated with depression in patients with Fabry disease.

Method

Qualitative systematic review of the literature of studies conducting neuropsychological assessment or measuring the prevalence of depression in adults with Fabry disease using the preferred reporting items for systematic reviews and meta-analysis (PRISMA) guidelines where appropriate.

Results

There is some evidence for neuropsychological impairment in Fabry disease in executive functioning, information processing speed and attention, with preservation of: general intellectual functioning, memory, naming, perceptual functioning and global cognitive functioning. Prevalence rates of depression in Fabry disease ranged from 15 % to 62 %, with the largest study to date reporting a prevalence rate of 46 %. The most common factor associated with depression was neuropathic pain, both directly and indirectly by affecting social and adaptive functioning.

Conclusion

Our review suggests that Fabry disease may be associated with a characteristic pattern of cognitive deficits and a high prevalence of psychological disorders such as depression but highlights the limited available data. Exploring the nature of cognitive impairment in Fabry disease using standardised neuropsychological assessment, brain imaging and measures of depression is an important task for future research.
Literatur
Zurück zum Zitat Assareh A, Mather KA, Schofield PR, Kwok JBJ, Sachdev PS (2011) The genetics of white matter lesions. CNS Neurosci Ther 17:525–540PubMedCrossRef Assareh A, Mather KA, Schofield PR, Kwok JBJ, Sachdev PS (2011) The genetics of white matter lesions. CNS Neurosci Ther 17:525–540PubMedCrossRef
Zurück zum Zitat Brown FW, Lewine RJ, Hudgins PA, Risch SC (1992) White matter hyperintensity signals in psychiatric and nonpsychiatric subjects. Am J Psychiatry 149:620–625PubMed Brown FW, Lewine RJ, Hudgins PA, Risch SC (1992) White matter hyperintensity signals in psychiatric and nonpsychiatric subjects. Am J Psychiatry 149:620–625PubMed
Zurück zum Zitat Burlina AP (2010) Neurological manifestations and psychological aspects of Fabry disease. Clin Ther 32C:88–89CrossRef Burlina AP (2010) Neurological manifestations and psychological aspects of Fabry disease. Clin Ther 32C:88–89CrossRef
Zurück zum Zitat Cole AL, Lee PJ, Hughes DA, Deegan PB, Waldek S, Lachmann RH (2007) Depression in adults with Fabry disease: a common and underdiagnosed problem. J Inherit Metab Dis 30:943–951PubMedCrossRef Cole AL, Lee PJ, Hughes DA, Deegan PB, Waldek S, Lachmann RH (2007) Depression in adults with Fabry disease: a common and underdiagnosed problem. J Inherit Metab Dis 30:943–951PubMedCrossRef
Zurück zum Zitat Crosbie TW, Packman W, Packman S (2009) Psychological aspects of patients with Fabry disease. J Inherit Metab Dis 32:745–753PubMedCrossRef Crosbie TW, Packman W, Packman S (2009) Psychological aspects of patients with Fabry disease. J Inherit Metab Dis 32:745–753PubMedCrossRef
Zurück zum Zitat Delano-Wood L, Abeles N, Sacco JM, Wierenga CE, Horne NR, Bozoki A (2008) Regional white matter pathology in mild cognitive impairment: differential influence of lesion type on neuropsychological functioning. Stroke 39:794–799PubMedCrossRef Delano-Wood L, Abeles N, Sacco JM, Wierenga CE, Horne NR, Bozoki A (2008) Regional white matter pathology in mild cognitive impairment: differential influence of lesion type on neuropsychological functioning. Stroke 39:794–799PubMedCrossRef
Zurück zum Zitat Elstein D, Doniger GM, Altarescu G (2012) Cognitive testing in Fabry disease: pilot using a brief computerised assessment tool. Isr Med Assoc 14:624–628 Elstein D, Doniger GM, Altarescu G (2012) Cognitive testing in Fabry disease: pilot using a brief computerised assessment tool. Isr Med Assoc 14:624–628
Zurück zum Zitat Fellgiebel A, Mazanek M, Whybra C et al (2006) Pattern of microstructural brain tissue alterations in Fabry disease: a diffusion tensor imaging study. J Neurol 253:780–787PubMedCrossRef Fellgiebel A, Mazanek M, Whybra C et al (2006) Pattern of microstructural brain tissue alterations in Fabry disease: a diffusion tensor imaging study. J Neurol 253:780–787PubMedCrossRef
Zurück zum Zitat Fellgiebel A, Albrecht J, Dellani PR, Schermuly I, Stoeter P, Muller MJ (2007) Quantification of brain tissue alterations in Fabry disease using diffusion tensor imaging. Acta Paediatr 96:33–36CrossRef Fellgiebel A, Albrecht J, Dellani PR, Schermuly I, Stoeter P, Muller MJ (2007) Quantification of brain tissue alterations in Fabry disease using diffusion tensor imaging. Acta Paediatr 96:33–36CrossRef
Zurück zum Zitat Fellgiebel A, Wolf DO, Kolodny E, Muller MJ (2012) Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease. J Inherit Metab Dis 35:363–367PubMedCrossRef Fellgiebel A, Wolf DO, Kolodny E, Muller MJ (2012) Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease. J Inherit Metab Dis 35:363–367PubMedCrossRef
Zurück zum Zitat Fossati P, Ergis AM, Allilaire JF (2002) Executive functioning in unipolar depression: a review. Encephale 28:97–107PubMed Fossati P, Ergis AM, Allilaire JF (2002) Executive functioning in unipolar depression: a review. Encephale 28:97–107PubMed
Zurück zum Zitat Gairing S, Wiest R, Metzler S, Theodorido A, Hoff P (2011) Fabry’s disease and psychosis: causality or coincidence? Psychopathology 44:201–204PubMedCrossRef Gairing S, Wiest R, Metzler S, Theodorido A, Hoff P (2011) Fabry’s disease and psychosis: causality or coincidence? Psychopathology 44:201–204PubMedCrossRef
Zurück zum Zitat Gold KF, Pastores GM, Botteman MF et al (2002) Quality of life of patients with Fabry disease. Qual Life Res 11:317–327PubMedCrossRef Gold KF, Pastores GM, Botteman MF et al (2002) Quality of life of patients with Fabry disease. Qual Life Res 11:317–327PubMedCrossRef
Zurück zum Zitat Grewal RP (1993) Psychiatric disorders in patients with Fabry’s disease. Int J Psychiatry Med 23:307–312PubMedCrossRef Grewal RP (1993) Psychiatric disorders in patients with Fabry’s disease. Int J Psychiatry Med 23:307–312PubMedCrossRef
Zurück zum Zitat Herrmann LL, Le Masurier M, Ebmeier KP (2008) White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry 79:619–624PubMedCrossRef Herrmann LL, Le Masurier M, Ebmeier KP (2008) White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry 79:619–624PubMedCrossRef
Zurück zum Zitat Jenkinson C (2000) The SF-36 physical and mental health summary measures: an example of how to interpret scores. J Health Serv Res Policy 3:92–96 Jenkinson C (2000) The SF-36 physical and mental health summary measures: an example of how to interpret scores. J Health Serv Res Policy 3:92–96
Zurück zum Zitat Jokinen H, Kalska H, Mantyla R et al (2005) White matter hyperintensities as a predictor of neuropsychological deficits post-stroke. J Neurol Neurosurg Psychiatry 76:1229–1233PubMedCentralPubMedCrossRef Jokinen H, Kalska H, Mantyla R et al (2005) White matter hyperintensities as a predictor of neuropsychological deficits post-stroke. J Neurol Neurosurg Psychiatry 76:1229–1233PubMedCentralPubMedCrossRef
Zurück zum Zitat Laaksonen SM, Roytta M, Jaaskelainen SK, Kantola I, Penttinen M, Falck B (2008) Neuropathic symptoms and findings in women with Fabry disease. Clin Neurophysiol 119:1365–1372PubMedCrossRef Laaksonen SM, Roytta M, Jaaskelainen SK, Kantola I, Penttinen M, Falck B (2008) Neuropathic symptoms and findings in women with Fabry disease. Clin Neurophysiol 119:1365–1372PubMedCrossRef
Zurück zum Zitat Laney DA, Gruskin DJ, Fernhoff PM et al (2010) Social-adaptive and psychological functioning of patients affected by Fabry disease. J Inherit Metab Dis 33:1–9CrossRef Laney DA, Gruskin DJ, Fernhoff PM et al (2010) Social-adaptive and psychological functioning of patients affected by Fabry disease. J Inherit Metab Dis 33:1–9CrossRef
Zurück zum Zitat Liston EH, Levine MD, Philippart M (1973) Psychosis in Fabry disease and treatment with Phenoxybenzamine. Arch Gen Psychiatry 29:402–403PubMedCrossRef Liston EH, Levine MD, Philippart M (1973) Psychosis in Fabry disease and treatment with Phenoxybenzamine. Arch Gen Psychiatry 29:402–403PubMedCrossRef
Zurück zum Zitat Low M, Nicholls K, Tubridy N et al (2007) Neurology of Fabry disease. Intern Med 37:436–447CrossRef Low M, Nicholls K, Tubridy N et al (2007) Neurology of Fabry disease. Intern Med 37:436–447CrossRef
Zurück zum Zitat MacDermot KD, Holmes A, Miners AH (2001a) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 38:750–760PubMedCentralPubMedCrossRef MacDermot KD, Holmes A, Miners AH (2001a) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 38:750–760PubMedCentralPubMedCrossRef
Zurück zum Zitat MacDermot KD, Holmes A, Miners AH (2001b) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38:769–775PubMedCentralPubMedCrossRef MacDermot KD, Holmes A, Miners AH (2001b) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38:769–775PubMedCentralPubMedCrossRef
Zurück zum Zitat Mehta A, Ginsberg L (2005) Natural history of the cerebrovascular complications of Fabry disease. Acta Paediatr 94:24–27CrossRef Mehta A, Ginsberg L (2005) Natural history of the cerebrovascular complications of Fabry disease. Acta Paediatr 94:24–27CrossRef
Zurück zum Zitat Meikle PJ, Hopwood JJ, Clague AA, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281:249–254PubMedCrossRef Meikle PJ, Hopwood JJ, Clague AA, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281:249–254PubMedCrossRef
Zurück zum Zitat Mendez MF, Stanley TM, Medel NM, Li Z, Tedesco DT (1997) The vascular dementia of Fabry’s disease. Dement Geriatr Cogn Disord 8:252–257PubMedCrossRef Mendez MF, Stanley TM, Medel NM, Li Z, Tedesco DT (1997) The vascular dementia of Fabry’s disease. Dement Geriatr Cogn Disord 8:252–257PubMedCrossRef
Zurück zum Zitat Miners AH, Holmes A, Sherr L, Jenkinson C, MacDermot KD (2002) Assessment of health-related quality of life in males with Anderson Fabry disease before therapeutic intervention. Qual Life Res 11:127–133PubMedCrossRef Miners AH, Holmes A, Sherr L, Jenkinson C, MacDermot KD (2002) Assessment of health-related quality of life in males with Anderson Fabry disease before therapeutic intervention. Qual Life Res 11:127–133PubMedCrossRef
Zurück zum Zitat Mohanraj R, Leach JP, Broome JC, Smith DF (2002) Neurological presentation of Fabry’s disease in a 52 year old man. J Neurol Neurosurg Psychiatry 73:340–342PubMedCentralPubMedCrossRef Mohanraj R, Leach JP, Broome JC, Smith DF (2002) Neurological presentation of Fabry’s disease in a 52 year old man. J Neurol Neurosurg Psychiatry 73:340–342PubMedCentralPubMedCrossRef
Zurück zum Zitat Muller MJ (2006) Neuropsychiatric and psychosocial aspects of Fabry disease. In: Mehta A, Beck M, Sunder-Plassmann G (eds) Fabry disease: perspectives from 5 years of FOS. Pharmagenesis Ltd, Oxford, pp 281–294 Muller MJ (2006) Neuropsychiatric and psychosocial aspects of Fabry disease. In: Mehta A, Beck M, Sunder-Plassmann G (eds) Fabry disease: perspectives from 5 years of FOS. Pharmagenesis Ltd, Oxford, pp 281–294
Zurück zum Zitat Muller MJ, Fellgiebel A, Scheurich A, Whybra C, Beck M, Muller KM (2006) Recurrent brief depression in a female patient with Fabry disease. Bipolar Disord 8:418–419PubMedCrossRef Muller MJ, Fellgiebel A, Scheurich A, Whybra C, Beck M, Muller KM (2006) Recurrent brief depression in a female patient with Fabry disease. Bipolar Disord 8:418–419PubMedCrossRef
Zurück zum Zitat Osborne TL, Jensen MP, Ehde DM, Hanley MA, Kraft G (2007) Psychosocial factors associated with pain intensity, pain-related interference and psychological functioning in persons with multiple sclerosis and pain. Pain 127:52–62PubMedCrossRef Osborne TL, Jensen MP, Ehde DM, Hanley MA, Kraft G (2007) Psychosocial factors associated with pain intensity, pain-related interference and psychological functioning in persons with multiple sclerosis and pain. Pain 127:52–62PubMedCrossRef
Zurück zum Zitat Sadek J, Shellhaas R, Camfield CS, Camfield PR, Burley J (2004) Psychiatric findings in four female carriers of Fabry disease. Psychiatr Genet 14:199–201PubMedCrossRef Sadek J, Shellhaas R, Camfield CS, Camfield PR, Burley J (2004) Psychiatric findings in four female carriers of Fabry disease. Psychiatr Genet 14:199–201PubMedCrossRef
Zurück zum Zitat Schermuly I, Muller MJ, Muller KM et al (2011) Neuropsychiatric symptoms and brain structural alterations in Fabry disease. Eur J Neurol 18:347–353PubMedCrossRef Schermuly I, Muller MJ, Muller KM et al (2011) Neuropsychiatric symptoms and brain structural alterations in Fabry disease. Eur J Neurol 18:347–353PubMedCrossRef
Zurück zum Zitat Segal P, Kohn Y, Pollak Y, Altarescu G, Galilli-Weisstub E, Raas-Rothschild A (2010) Psychiatric and cognitive profile in Anderson-Fabry patients: a preliminary study. J Inherit Metab Dis 33:429–436PubMedCrossRef Segal P, Kohn Y, Pollak Y, Altarescu G, Galilli-Weisstub E, Raas-Rothschild A (2010) Psychiatric and cognitive profile in Anderson-Fabry patients: a preliminary study. J Inherit Metab Dis 33:429–436PubMedCrossRef
Zurück zum Zitat Sexton CE, Mackay CE, Ebmeier KP (2012) A systematic review and meta-analysis of magnetic resonance imaging studies in late-life depression. Am J Geriatr Psychiatry 21:184–195CrossRef Sexton CE, Mackay CE, Ebmeier KP (2012) A systematic review and meta-analysis of magnetic resonance imaging studies in late-life depression. Am J Geriatr Psychiatry 21:184–195CrossRef
Zurück zum Zitat Smith MM, Mills JA, Epping EA, Westervelt HJ, Paulsen JS (2012) Depressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease. Neuropsychology 26:664–649PubMedCentralPubMedCrossRef Smith MM, Mills JA, Epping EA, Westervelt HJ, Paulsen JS (2012) Depressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease. Neuropsychology 26:664–649PubMedCentralPubMedCrossRef
Zurück zum Zitat Wang RY, Lelis A, Mirocha J, Wilcox WR (2007) Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med 9:34–45PubMedCrossRef Wang RY, Lelis A, Mirocha J, Wilcox WR (2007) Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med 9:34–45PubMedCrossRef
Zurück zum Zitat Yamadera M, Yokoe M, Beck G et al (2009) Amelioration of white-matter lesions in a patient with Fabry disease. J Neurol Sci 279:118–120PubMedCrossRef Yamadera M, Yokoe M, Beck G et al (2009) Amelioration of white-matter lesions in a patient with Fabry disease. J Neurol Sci 279:118–120PubMedCrossRef
Metadaten
Titel
Cognitive dysfunction and depression in Fabry disease: a systematic review
verfasst von
Fay E. Bolsover
Elaine Murphy
Lisa Cipolotti
David J. Werring
Robin H. Lachmann
Publikationsdatum
01.03.2014
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 2/2014
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-013-9643-x

Weitere Artikel der Ausgabe 2/2014

Journal of Inherited Metabolic Disease 2/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.